Comparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancersurgery on Perioperative Clinical Indexes、Inflammatory Reaction and Quality of Life Scores of Patients With Non-small Cell Lung Cancer
NCT05070026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68
Last updated 2022-08-16
Summary
Many recent studies have shown that surgical trauma will result in an immunosuppressive state. Combined with the effect of surgical stress, it will often lead to metabolic changes, systemic inflammatory response, and other problems. The body resists and removes the harmful factors through the inflammatory reaction. However, an excessive reaction will damage the normal tissues and cells of the body. The smooth recovery of the body needs to balance the degree of inflammatory reaction. Surgical patients will trigger different degrees of an inflammatory response due to different degrees of physical trauma, which runs through the process of postoperative recovery from the beginning of surgery and often prolongs the time of postoperative recovery. Reducing the intraoperative and postoperative inflammatory response of patients has always been the goal of surgeons, and a method is the reduction of surgical trauma.
The successful experience of the first single-port thoracoscopic wedge resection of the lung in 2004 provided us with a new surgical idea. Subsequently, a large number of domestic and international studies and case reports show that single-port thoracoscopic surgery is safe and feasible in lobectomy and segmental resection. With the rapid development of single-port thoracoscopic surgery in recent years, the scope of application and clinical efficacy of the surgery are gradually becoming equivalent to the traditional three-port thoracoscopic surgery, which can ensure the safety of the operation and complete tumor resection, and has its own characteristics and advantages compared with the traditional three-port thoracoscopic surgery. The reduction of incisions can significantly improve the postoperative pain and recovery of patients and wound healing.
In addition, single-port thoracoscopic surgery also has a subtle improvement in patients' intraoperative and postoperative inflammatory response compared with traditional three-port thoracoscopic surgery. In this study, we compared and analyzed the intraoperative and postoperative inflammatory factor levels of single-port thoracoscopic surgery and three-port thoracoscopic surgery in patients with non-small cell lung cancer (NSCLC). Through the comparison of the measured values, we further discussed the advantages of single-port thoracoscopic surgery in reducing inflammatory response and its application and promotion value in the treatment of patients with NSCLC compared with traditional three-port thoracoscopic surgery.
Conditions
- Video-assisted Thoracoscopic Surgery
- Inflammatory Reaction
- Life Scores
Interventions
- OTHER
-
uni-portal VATS group
patients received pulmonary lobectomy under general anesthesia by using uni-portal VATS method
- OTHER
-
three port VATS group
patients received pulmonary lobectomy under under general anesthesia by using three port VATS method
Sponsors & Collaborators
-
Shengjing Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- China
Study Locations
More Related Trials
-
Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC
NCT07003490 ·Status: RECRUITING ·Phase: NA
-
Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study
NCT06028412 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Analysis of Risk Factors of Postoperative Pulmonary Infection in Patients With Esophageal Cancer
NCT05740852 ·Status: COMPLETED
-
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)
NCT06577792 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer
NCT07166003 ·Status: RECRUITING
-
Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer
NCT02992353 ·Status: UNKNOWN ·Phase: NA
-
A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer
NCT01102517 ·Status: UNKNOWN ·Phase: NA
-
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
NCT03786003 ·Status: RECRUITING ·Phase: NA
-
Diaphragmatic Thickness and Functional Exercise Capacity in Lobectomy Surgeries With Thoracotomy and VATS
NCT05669196 ·Status: COMPLETED
-
Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm
NCT06634979 ·Status: RECRUITING ·Phase: NA
-
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
NCT06534489 ·Status: RECRUITING
-
Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC)
NCT01337037 ·Status: UNKNOWN
-
Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer
NCT07099105 ·Status: COMPLETED
-
Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer
NCT03010033 ·Status: UNKNOWN ·Phase: NA
-
Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery
NCT05270616 ·Status: RECRUITING ·Phase: NA
-
Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT
NCT07327736 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients
NCT03613467 ·Status: COMPLETED
-
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
NCT02288026 ·Status: UNKNOWN
-
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD
NCT02504801 ·Status: UNKNOWN ·Phase: PHASE4
-
Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
NCT07135856 ·Status: RECRUITING
-
Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion
NCT02011997 ·Status: UNKNOWN ·Phase: PHASE3
-
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
NCT07256002 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
NCT03429673 ·Status: COMPLETED
-
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
NCT06503744 ·Status: RECRUITING ·Phase: NA
-
Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer
NCT06907160 ·Status: RECRUITING